|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/54 | |
| C12N 7/04 | |||
| C12N 15/863 | |||
| A61K 35/76 | |||
| A61K 39/39 | |||
| A61K 48/00 |
| (11) | Number of the document | 2415783 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11183721.7 |
| Date of filing the European patent application | 2007-10-16 | |
| (97) | Date of publication of the European application | 2012-02-08 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 852390 P | 2006-10-16 | US | |
| 933050 P | 2007-06-04 | US | |
| 950587 P | 2007-07-18 | US | |
| 994794 P | 2007-09-21 | US |
| (72) |
Frentzen, Alexa, US
Chen, Nanhai, US
Zhang, Qian, US
Yu, Yong, US
Szalay, Aladar, US
|
| (73) |
Genelux Corporation,
3030 Bunker Hill Street Suite 310, San Diego, California 92109,
US
|
| (54) | Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
| Modified vaccinia virus strains for use in a diagnostic and therapeutic method |